PubMed · 14917490
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
J C GUIMARAES. 1951-11-24. [Problems in allergy; case report].. https://pubmed.ncbi.nlm.nih.gov/14917490/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
We expose you the revised nomenclature for allergy following the proposal of the European Academy of Allergy and Clinical Immunology (EAACI). We will review here, as faithfully as possible, the distinct definitions and the right terms to use in allergy and in the other medical branches.
Explore the source record for details and available documents.
Interleukin-1 (IL-1), a polypeptide product of various cells, is one of the key mediators of the body's response to microbial invasion, inflammation, immunological reactions, and tissue injury. IL-1 is a prominent member of a group of polypeptide mediators now called "cytokines." Current evidence suggests that IL-1 is not produced in health but that any perturbation such as inflammation or even slight injury triggers the expression of IL-1 genes. The biological effects of IL-1 are manifested in nearly every tissue and organ. These include various proinflammatory effects such as increased production of arachidonate metabolites, synovial cell proteases, activation of basophils, eosinophils and neutrophils, endothelial cell adhesiveness, and stimulation of lymphocyte responses. Control of IL-1 synthesis in certain diseases is often appropriate. Although corticosteroids reduce both the transcription and translation of IL-1, we have recently investigated the effect of dietary supplementation with N-3 (omega-3) fatty acids in human volunteers. The results indicate that increasing the amount of N-fatty acids in the diet decreases the ability of blood mononuclear cells to synthesize IL-1 in vitro. It is suggested that the ameliorative effects of N-3 fatty acid dietary supplements in patients with hypersensitive diseases may be, in part, the result of decreased IL-1 production.